James A. Mailliard - Concepedia

Author

James A. Mailliard

Mayo Clinic

Also Known As

JAMES A. MAILLIARD, James A Mailliard, James A. Mailliard, James Mailliard, James a. Mailliard

Publications

9.1K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Iowa Oncology Research Association Duluth Clinic Missouri Valley Cancer Consortium Creighton University

About

James A. Mailliard is an author at Mayo Clinic specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	30	3K
2	Health Sciences	12	12	967
3	Public Health	1	1	20
4	Anesthesia	1	1	26
5	Biostatistics	1	1	20

James A. Mailliard

Publications

Citations

H-Index

Page 1

	Year	Citations
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma Charles G. Moertel, Thomas R. Fleming, John S. Macdonald, New England Journal of Medicine	1990	2.2K
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial Charles L. Loprinzi, John W. Kugler, Jeff A Sloan, The Lancet Breast OncologyMedicineBreast CancerPharmacotherapyHot Flashes	2000	733
Phase II/III Study of Doxorubicin With Fluorouracil Compared With Streptozocin With Fluorouracil or Dacarbazine in the Treatment of Advanced Carcinoid Tumors: Eastern Cooperative Oncology Group Study E1281 Weijing Sun, Stuart R. Lipsitz, Paul J. Catalano, Journal of Clinical Oncology	2005	355
Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study Aminah Jatoi, Harold E. Windschitl, Charles L. Loprinzi, Journal of Clinical Oncology Weight ManagementPharmacotherapyCancer-associated AnorexiaObesityFunctional Assessment	2002	353
Randomized Comparison of Megestrol Acetate Versus Dexamethasone Versus Fluoxymesterone for the Treatment of Cancer Anorexia/Cachexia Charles L. Loprinzi, John W. Kugler, Jeff A. Sloan, Journal of Clinical Oncology	1999	342
An Eicosapentaenoic Acid Supplement Versus Megestrol Acetate Versus Both for Patients With Cancer-Associated Wasting: A North Central Cancer Treatment Group and National Cancer Institute of Canada Collaborative Effort Aminah Jatoi, Kendrith M. Rowland, Charles L. Loprinzi, Journal of Clinical Oncology	2004	294
Phase III Evaluation of Fluoxetine for Treatment of Hot Flashes Charles L. Loprinzi, Jeff A. Sloan, Edith A. Perez, Journal of Clinical Oncology Breast OncologyMenopausal Hormone TherapyPharmacotherapyHot FlashesPre-clinical Pharmacology	2002	264
A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia Carl G. Kardinal, Charles L. Loprinzi, Daniel J. Schaid, Cancer OncologyControlled TrialPsychotropic MedicationMetronomic TherapyPharmacology	1990	226
The Outcome of Combined-Modality Therapy for Stage III Non–Small-Cell Lung Cancer in the Elderly Steven E. Schild, Philip J. Stella, Susan M. Geyer, Journal of Clinical Oncology	2003	224
Phase III, Randomized, Double-Blind Study of Epoetin Alfa Compared With Placebo in Anemic Patients Receiving Chemotherapy Thomas E. Witzig, Peter T. Silberstein, Charles L. Loprinzi, Journal of Clinical Oncology	2004	209

Page 1